Autism Risk-Associated Genes in a Latin American Cohort Broadly Overlap with Those in Studies Focused on European Ancestry
Background
Genes associated with autism risk in a Latin American cohort broadly overlapped with those identified in earlier studies focused mainly on participants of European ancestry. The findings are based on gene sequencing data from a large Latin American cohort and were described in a research briefing published by Nature Medicine on March 30, 2026. The study examined whether risk-associated genes identified in previous research were also observed in participants from a different background.
Key findings
According to the briefing, genes statistically significantly associated with autism risk in the Latin American cohort substantially overlapped with genes identified in previous genome-wide sequencing studies focused mainly on participants of European ancestry. This indicates considerable sharing of risk-associated genes across the studies compared. It does not establish that all genes or individual variants are identical, or that the magnitude of risk is equal across populations.
Significance and outlook
The findings show that the Latin American cohort and studies focused on European ancestry share autism risk-associated genes. However, this conclusion cannot readily be generalized to all ancestry groups. The available material is a public preview of a briefing summarizing the original study; sample size, the proportion of overlap, variant-specific effects, and detailed analysis conditions have not been confirmed. Improved genetic screening performance or an expanded set of therapeutic targets cannot be considered demonstrated outcomes of this material.
Source: Nature Medicine research briefing
EMOTION_TAG: interesting
Nature Medicine, Published online: 30 March 2026; doi:10.1038/s41591-026-04259-z. Genetic sequencing data from a large cohort of Latin American individuals showed that the genes significantly associated with autism risk extensively overlapped with those found in genome-wide sequencing studies in people of predominantly European ancestry.
These findings provide a basis for comparing results from autism genetics studies that include people from different ancestry backgrounds. Follow-up research could compare risk-associated genes identified in the Latin American cohort with those from earlier studies and assess the reproducibility of the findings. Gene-level overlap alone, however, makes it difficult to determine how accurately an individual's autism risk can be predicted. Variant-specific effects and test performance must be validated separately before applying the findings to clinical screening or treatment development.